Amarantus Bioscience Holdings, Inc. (AMBS: OTCQB) | Amarantus BioScience Opens Investigational New Drug (IND) Application With the U.S. Food and Drug Administration Allowing the Start of a Phase 2b Program of Eltoprazine in Parkinson's Disease Levodopa-Induced Dyskinesia
(0)
(0)